New Evidence Defines Optimal Methotrexate Dosing Regimen in Psoriasis

He disclosed that he has served as a consultant and speaker for and/or participated in clinical trials sponsored by Abbott, which funded the M10-255 trial, as well as Biogen Idec, Bristol-Myers-Squibb, Centocor, Merck Serono, Schering-Plough, UCB Pharma, and Wyeth.